In specific cases, or from a public or animal health or environment perspective, it is necessary to complement the safety and efficacy data available at the time of authorisation with additional information following the placing of the veterinary medicinal product on the market.
I gcásanna sonracha, nó ó thaobh sláinte phoiblí nó sláinte ainmhithe nó an chomhshaoil de, is gá faisnéis bhreise a gheofar tar éis an táirge íocshláinte tréidliachta a chur ar an margadh a chur leis na sonraí maidir le sábháilteacht agus éifeachtacht atá ar fáil tráth an údaraithe.